plasma glycolate concentrations found previously (15), because heating may promote glycolate generation from precursors in plasma or contamination from the acid. Despite the differences between our earlier and current techniques, the recovery of [14C}glycolate was the same in each (-97%)
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Interference of Carbamylated and Acetylated Hemoglobins in Assays of Glycohemoglobin by HPLC, Electrophoresis,Affinity Chromatography, and Enzyme Immunoassay
Cas W. Weykamp,' Thea J. Penders,' Carla W. M. Siebelder,' Frits A. J. Muskiet,2 and Willem van der Slik2
In vitro-synthesized carbamylated and acetylated hemoglobins interfered in assays of glycohemoglobin by HPLC and electrophoresis but had no effects on results obtained by affinity chromatography and enzyme immunoassay. Correlations between long-term serum urea concentrations and glycohemoglobin percentages revealed that, in vivo, carbamylated hemoglobin equivalent to 0.063% of total hemoglobin is formed for every 1 mmol/L of serum urea. The use of acetylsalicylate, either chronically in small doses (200-300 mg/day) or for 1 week at 2000 mg/day, did not cause significant interference from acetyl- ' 
Subjects and Methods
Patients and Control Subjects
We studied venous blood samples, both EDTA-anticoagulated and coagulated, from the following groups of patients (12) . Briefly, carbamylated hemoglobin is converted into carbamylated globin with hydrochloric acid/acetone and hydrolyzed in acetic acid! hydrochloric acid at 100 #{176}C to form valine-hydantoin. The latter is identified by gas chromatography.
In vitro acetylation of a hemolysate.3
Washed erythrocytes were obtained as described above. To 4.5 mL of washed packed cells we added 4.0 mL of 0.01 mol/L NaCN solution and 8.0 mL of 40 mmol/L acetylsalicylate solution in 0.01 moIJL NaH2PO4 buffer (pH adjusted to 6.9 with 4 mol/L HC1 after the addition of the acetylsalicylate) (11 
3.2
All samples analyzed in thplicate. Significantly dIfferent from basal hemolysate (P <0.05).
-' u- 
Discussion
The present data (Figure 1, Table 1) show that carbamylated and acetylated hemoglobins prepared in vitro interfere with the HPLC and electrophoretic methods widely used to assay glycohemoglobin. The hemoglobin derivatives have no effects on methods that make use of affinity chromatography and enzyme immunoassay. These results are in agreement with previous observations by Bannon et al. (5) we merely studied the differences between results for glycohemoglobin obtained by the various methods and related these to the mean serum urea concentrations.
The regression lines in Figure 2 show that only glycohemoglobin differences related to the mean serum urea concentrations are the differences between results of carbamylated hemoglobin-sensitive (HPLC and elec- The interfering effect of in vivo-formed acetylated hemoglobin on the assay of glycohemoglobin was studied in patients being chronically treated with acetylsalicylate (Table 2 ) and in volunteers taking a large dose for 1 week. However, these groups showed no differences from the age-matched control group (Table 2) or from basal values, in agreement with previous observations. Compared with the control subjects, patients with rheumatoid arthritis who were treated with 4 g of salicylate per day had a 1.5% (absolute difference) greater glycohemoglobin percentage, as determined by HPLC (11) . One volunteer showed an absolute increase of 0.4% after 
